Akers Biosciences, Inc. (51) | Purchase Agreements (8)
Recent Contracts
-
Asset Purchase Agreement, dated November 11, 2020, by and between MyMD Pharmaceuticals, Inc. and Supera Pharmaceuticals, Inc
(Filed With SEC on May 18, 2021)
-
Form of Securities Purchase Agreement, dated November 11, 2020, by and between Akers Biosciences, Inc. and purchasers named therein
(Filed With SEC on November 12, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on August 13, 2020)
-
Amendment No. 1 to the Membership Interest Purchase Agreement, dated May 14, 2020
(Filed With SEC on May 15, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on May 15, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on April 8, 2020)
-
Membership Interest Purchase Agreement
(Filed With SEC on March 24, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on November 29, 2019)
